Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors

被引：23
|
作者：
Rosen, LS [1 ]
机构：
[1] Canc Inst Med Grp, Dev Therapeut, Santa Monica, CA 90404 USA
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期
关键词：
D O I：
10.1053/sonc.2002.37416
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 32
页数：5
相关论文
共 50 条
  • [41] Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors
    Van den Wyngaert, T.
    Delforge, M.
    Doyen, C.
    Duck, L.
    Wouters, K.
    Delabaye, I.
    Wouters, C.
    Wildiers, H.
    SUPPORTIVE CARE IN CANCER, 2013, 21 (12) : 3483 - 3490
  • [42] The Association between Fever and Prognosis in Lung Cancer Patients with Bone Metastases Receiving Zoledronic Acid
    Sunaga, Tomiko
    Shimamoto, Kazushi
    Nakamura, Shoko
    Takahashi, Noriko
    Higashino, Mayumi
    Hozumi, Tomomi
    Matsui, Mitsuki
    Nagatani, Akiko
    Kokubu, Fumio
    Kogo, Mari
    Sasaki, Tadanori
    CHEMOTHERAPY, 2017, 62 (06) : 327 - 333
  • [43] Effect of the number of bone lesions on efficacy of zoledronic acid for prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors.
    Shirina, N.
    Coleman, R. E.
    Chen, Y. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 475S - 475S
  • [44] TREATMENT OF BONE METASTASES FROM HEPATOCELLULAR CARCINOMA WITH ZOLEDRONIC ACID
    Addeo, Raffaele
    Montella, Liliana
    Palmieri, Giovannella
    Caraglia, Michele
    Cennamo, Gregorio
    Guarrasi, Rosario
    Iodice, Patrizia
    Mamone, Rosanna
    Faiola, Vincenzo
    D'Agostino, Alberto
    Capasso, Elena
    Maiorino, Luigi
    Pizza, Carmine
    Montesarchio, Vincenzo
    Del Prete, Salvatore
    ANNALS OF ONCOLOGY, 2009, 20
  • [45] Zoledronic acid (ZOMETA): a significant improvement in the treatment of bone metastases
    Nagy, Z
    PATHOLOGY & ONCOLOGY RESEARCH, 2005, 11 (03) : 186 - 187
  • [46] Zoledronic acid and atrial fibrillation in cancer patients with bone metastases
    Aksoy, S.
    Dizdar, O.
    Turgut, D.
    Dede, D. Sener
    Arslan, C.
    Harputluoglu, H.
    Altundag, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] Regarding "Recommendations for zoledronic acid treatment of patients with bone metastases"
    Parles, K
    ONCOLOGIST, 2005, 10 (05): : 304 - 305
  • [48] Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases
    Chen, TL
    Berenson, J
    Vescio, R
    Swift, R
    Gilchick, A
    Goodin, S
    LoRusso, P
    Ma, PM
    Ravera, C
    Deckert, F
    Schran, H
    Seaman, J
    Skerjanec, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11): : 1228 - 1236
  • [49] Zoledronic acid for the prevention of bone metastases in patients with breast cancer
    Coleman, R.
    Gralow, J.
    Bell, R.
    Lipton, A.
    EJC SUPPLEMENTS, 2004, 2 (03): : 74 - 75
  • [50] Efficacy and Safety of Denosumab for the Treatment of Bone Metastases in Patients with Advanced Cancer
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (08) : 663 - 669
12345